2023 Fall
MCELLBI 153 001 - LEC 001
Molecular Therapeutics
Sarah A Stanley, Andrew Dillin
Class #:25487
Units: 4
Instruction Mode:
In-Person Instruction
Offered through
Molecular and Cell Biology
Current Enrollment
Total Open Seats:
0
Enrolled: 204
Waitlisted: 0
Capacity: 204
Waitlist Max: 30
No Reserved Seats
Hours & Workload
3 hours of instructor presentation of course materials per week, 8 hours of outside work hours per week, and 1 hours of the exchange of opinions or questions on course material per week.
Final Exam
MON, DECEMBER 11TH
08:00 am - 11:00 am
Genetics & Plant Bio 100
Dwinelle 145
Other classes by Sarah A Stanley
Other classes by Andrew Dillin
Course Catalog Description
The overarching goal of MCB 153 is to inform our MCB majors how therapeutics are developed and created. After completing this course, students will have a firm understanding on the mechanism of action of several therapies used to fight disease. The course will cover areas such as the discovery and refinement of antibiotics, anti-virals, cancer therapies, CRISPR0-based therapies. Furthermore, MCB 153 will delve into disease areas not covered in other courses, such as autoimmune diseases, cardiovascular diseases and neurological disease. Lastly, MCB 153 will implement a “case study” for each topic displaying real world challenges and solutions to treating complex diseases.
Rules & Requirements
Repeat Rules
Course is not repeatable for credit.
Reserved Seats
Current Enrollment
No Reserved Seats
Textbooks & Materials
See class syllabus or https://calstudentstore.berkeley.edu/textbooks for the most current information.
Guide to Open, Free, & Affordable Course Materials